This inventor holds 28 USPTO granted patents and 9 published patent applications and 3 EPO patents, primarily in Nanoparticle Vaccines. Top assignees: The United States of America, as Represented by the Secretary, Department of Health and Human Services, The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc., Dartmouth College. Active years: 2018-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Chevy Chase, MD (US) (2018 - 2024)
- North Bethesda, MD (US) (2024)
Company Filing History:
29 out of 3,696 
4 out of 196 
2 out of 708 
Years Active: 2018-2026
Areas of Expertise:
Title: Unveiling the Innovations of Inventor Masaru Kanekiyo
Introduction: Masaru Kanekiyo, a prolific inventor based in Chevy Chase, MD, has made significant contributions in the field of vaccines and viral infections. With an impressive track record of 20 patents, his latest inventions focus on developing vaccines that elicit broadly protective anti-influenza antibodies and prefusion coronavirus spike proteins.
Latest Patents:
1. Stabilized influenza hemagglutinin stem region trimers and uses thereof: These innovative vaccines comprise nanoparticles displaying HA trimers from the influenza virus on their surface. The fusion proteins self-assemble, generating HA-displaying nanoparticles that specifically target the stem region of an influenza HA protein.
2. Prefusion coronavirus spike proteins and their use: Kanekiyo's patents introduce coronavirus S ectodomain trimers stabilized in a prefusion conformation. These proteins, along with nucleic acid molecules and vectors encoding them, serve as potent tools in generating immune responses and treating or preventing coronavirus infections.
Career Highlights:
Masaru Kanekiyo has left a remarkable imprint on the field of bioengineering and virology through his research and patent portfolio. Notably, he has worked with prestigious institutions such as The United States of America, represented by the Department of Health and Human Services, and The Scripps Research Institute.
Collaborations:
Kanekiyo's innovative endeavors have been further enriched by collaborations with accomplished colleagues such as Barney S Graham and Jeffrey C Boyington. Together, they have propelled advancements in vaccine development and antiviral strategies.
Conclusion:
In conclusion, Inventor Masaru Kanekiyo's dedication to pioneering groundbreaking solutions in the realm of vaccines and viral infections is truly commendable. His latest patents underscore his commitment to enhancing global health and combating infectious diseases. We eagerly anticipate the future innovations that will undoubtedly emerge from his inventive prowess.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile